Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPCAT: t-PA Dwells for CVC Complications
NCT03672006Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in catheter-related thrombosis (CRT), central venous catheter-associated bloodstream infection (CLABSI), sponsored by Medical College of Wisconsin. Started Apr 2019; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
catheter-related thrombosis (CRT)central venous catheter-associated bloodstream infection (CLABSI)
Beyond the preview
Go deeper on NCT03672006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672006.